Trademark: 77644527
Word
VIGLAFE
Status
Dead
Status Code
606
Status Date
Monday, August 1, 2011
Serial Number
77644527
Mark Type
4000
Filing Date
Wednesday, January 7, 2009
Published for Opposition
Tuesday, October 6, 2009
Abandoned Date
Monday, August 1, 2011

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Events
Aug 1, 2011
Abandonment Notice Mailed - No Use Statement Filed
Aug 1, 2011
Abandonment - No Use Statement Filed
Nov 20, 2010
Notice Of Approval Of Extension Request Mailed
Nov 19, 2010
Extension 2 Granted
Nov 16, 2010
Extension 2 Filed
Nov 16, 2010
Teas Extension Received
Jun 15, 2010
Notice Of Approval Of Extension Request Mailed
Jun 14, 2010
Extension 1 Granted
May 21, 2010
Extension 1 Filed
Jun 14, 2010
Case Assigned To Intent To Use Paralegal
May 21, 2010
Teas Extension Received
Dec 28, 2009
Attorney Revoked And/Or Appointed
Dec 28, 2009
Teas Revoke/Appoint Attorney Received
Dec 29, 2009
Noa Mailed - Sou Required From Applicant
Oct 6, 2009
Published For Opposition
Sep 16, 2009
Notice Of Publication
Aug 29, 2009
Law Office Publication Review Completed
Aug 29, 2009
Assigned To Lie
Aug 26, 2009
Approved For Pub - Principal Register
Aug 25, 2009
Teas/Email Correspondence Entered
Aug 24, 2009
Correspondence Received In Law Office
Aug 24, 2009
Teas Response To Office Action Received
Mar 24, 2009
Non-Final Action Mailed
Mar 23, 2009
Non-Final Action Written
Mar 23, 2009
Assigned To Examiner
Jan 12, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24